Health Me Medical

Emergency

911

Add doctors or trusted contacts with phone numbers for quick dial

Finish setting up your health profile

Takes about 2 minutes — tailors your AI care team to you.

Start setup

Access restricted

Dental and private practice onboarding is available to Health Me admins and approved sub-contractors only. Sub-contractors: open the link from your approved portal or approval email. If you believe you should have access, please contact Health Me support.

Health Me Medical Center — Quality Care for a Healthier Tomorrow. No co-pays, free healthcare, free dental care, free eye care, and 24/7 access. AI doctor consultation, virtual consultations, AI nurse, mental health specialist, and much more.

Health Me Medical Center is an AI-powered wellness companion, not a medical provider. It provides health information and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for medical concerns. In an emergency, call 911.

View Terms of Service & Privacy Policy

Health News 24/7News

1. The FDA approved atezolizumab in combination with chemotherapy for the adjuvant treatment of stage III mismatch repair–deficient colon cancer on October 8, 2026. ◆ 2. On October 7, 2026, the FDA approved remibrutinib, marketed as Rhapsido, as the first oral treatment for symptomatic dermographism in adults. ◆ 3. UAB researchers recently utilized high-resolution micro/nano computed tomography to reveal that human tuberculosis granulomas are cylindrical rather than spherical. ◆ 4. The Niederweis lab at UAB successfully visualized the outer membrane of Mycobacterium tuberculosis for the first time using cryo-electron microscopy. ◆ 5. UAB scientists are currently advancing metallomics research to develop noninvasive imaging techniques for detecting tuberculosis-specific lesions. ◆ 6. Public health officials are addressing a recent tuberculosis outbreak in Kansas as researchers emphasize the need for improved diagnostic and treatment infrastructure. ◆ 7. The University of Nebraska Medical Center released new medical research highlights on October 8, 2026, focusing on innovative educational engagement programs. ◆ 8. OncLive reported on October 9, 2026, that recent regulatory updates include new dosing schedules for nivolumab in oncology patients. ◆ 9. The FDA continues to evaluate new therapeutic biological products as part of its ongoing 2026 drug approval cycle. ◆ 10. Medical experts are highlighting the critical importance of recognizing persistent cough and fever as key symptoms in the ongoing effort to combat tuberculosis.1. The FDA approved atezolizumab in combination with chemotherapy for the adjuvant treatment of stage III mismatch repair–deficient colon cancer on October 8, 2026. ◆ 2. On October 7, 2026, the FDA approved remibrutinib, marketed as Rhapsido, as the first oral treatment for symptomatic dermographism in adults. ◆ 3. UAB researchers recently utilized high-resolution micro/nano computed tomography to reveal that human tuberculosis granulomas are cylindrical rather than spherical. ◆ 4. The Niederweis lab at UAB successfully visualized the outer membrane of Mycobacterium tuberculosis for the first time using cryo-electron microscopy. ◆ 5. UAB scientists are currently advancing metallomics research to develop noninvasive imaging techniques for detecting tuberculosis-specific lesions. ◆ 6. Public health officials are addressing a recent tuberculosis outbreak in Kansas as researchers emphasize the need for improved diagnostic and treatment infrastructure. ◆ 7. The University of Nebraska Medical Center released new medical research highlights on October 8, 2026, focusing on innovative educational engagement programs. ◆ 8. OncLive reported on October 9, 2026, that recent regulatory updates include new dosing schedules for nivolumab in oncology patients. ◆ 9. The FDA continues to evaluate new therapeutic biological products as part of its ongoing 2026 drug approval cycle. ◆ 10. Medical experts are highlighting the critical importance of recognizing persistent cough and fever as key symptoms in the ongoing effort to combat tuberculosis.